View Related Sites
Cambridge Assessment Admissions Testing
Administering our tests
You are here:
Cambridge Assessment Admissions Testing, developers of - the BioMedical Admissions Test (BMAT) - is supporting the UK Medical Applicant Cohort Study, one of the largest studies ever undertaken into what motivates future UK medical students. The Study is led by researcher Dr Katherine Woolf, of UCL and funded by the National Institute for Health Research. It was launched in response to current shortfalls in NHS doctor numbers. By giving insights into what interests and engages future medical students, the Study will help improve the support given to future medical applicants.
Cambridge Assessment Admissions Testing is promoting the Study directly to its prospective UK BMAT test-takers- students hoping to study at a medical school where BMAT is part of the admissions process which includes the Universities of Cambridge, Oxford, Brighton, Lancaster and Leeds. BMAT test-takers will be invited to complete the study questionnaire, which they can do any time from now until 15th October 2019.
‘We were delighted to be asked to actively promote the Cohort Study to our BMAT community,’ comments Andy Chamberlain, Head of Cambridge Assessment Admissions Testing. ‘The Study will help shape the future application process for NHS doctors, a process in which BMAT continues to play an important role.’
A UK Medical Applicant Cohort Study participant commented: 'I found this questionnaire helpful, it reminded me of why I wanted to apply to a medical school in the first place and my current set of skills to see what else I need to for my application. I hope my answers can help future medical students in any way.'
Notes to editors